HIV-associated nephropathy: an urban epidemic.

Human immunodeficiency virus-associated nephropathy (HIVAN) is the most common form of chronic renal disease in HIV-1-seropositive patients. Over 85% of cases of HIVAN occur in African-American patients and it is the third leading cause of ESRD in blacks age 20 to 64. Changes in incidence rates of HIVAN have coincided with changes in AIDS incidence rates. The demographics of the AIDS/HIV-1 epidemic indicate that the risk pool for HIVAN will continue to grow and that urban Nephrology centers will continue to see high rates of HIVAN. In addition, improvements in survival rates of HIV-1-seropositive patients on hemodialysis and improved treatment of HIVAN with highly active antiretroviral therapy (HAART) and angiotensin-converting enzyme (ACE)-inhibitors will result in an increased prevalence of HIVAN in the end-stage renal disease (ESRD) and pre-ESRD patient populations.

[1]  J. Grady,et al.  Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  M. Alter,et al.  National Surveillance of Dialysis‐Associated Diseases in the United States, 1997 , 2000, Seminars in dialysis.

[3]  P. Klotman,et al.  HIV-associated nephropathy. , 1999, Kidney international.

[4]  B. Freedman,et al.  Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  P. Klotman,et al.  HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. , 1999, Kidney international.

[6]  P. Klotman,et al.  The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. , 1998, Seminars in nephrology.

[7]  V. D’Agati,et al.  Renal pathology of human immunodeficiency virus infection. , 1998, Seminars in nephrology.

[8]  S. Sivak,et al.  Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. , 1997, Journal of the American Society of Nephrology : JASN.

[9]  E. Friedman,et al.  Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  J. Bourgoignie,et al.  Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. , 1988, Kidney international.

[11]  M. Fischl,et al.  Glomerular lesions in the acquired immunodeficiency syndrome. , 1984, Annals of internal medicine.

[12]  E A Friedman,et al.  Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. , 1984, The New England journal of medicine.